Related Experiment Videos
Mast cell-dependent effector pathways and cutaneous bullous disorders
Springer Seminars in Immunopathology
|June 1, 1981
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cutaneous mucinosis of infancy: report of a rare case and review of the literature.
Dermatology online journal·2019
Coexistence of Eph receptor B1 and ephrin B2 in port-wine stain endothelial progenitor cells contributes to clinicopathological vasculature dilatation.
The British journal of dermatology·2017
Neuropeptide Y expression in primary cutaneous melanoma.
Journal of the European Academy of Dermatology and Venereology : JEADV·2016
Delayed type IV hypersensitivity reaction to porcine acellular dermal matrix masquerading as infection resulting in multiple debridements.
Hernia : the journal of hernias and abdominal wall surgery·2015
Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser.
The British journal of dermatology·2014
Activating and inhibitory FcgammaRs in autoimmune disorders.
Springer seminars in immunopathology·2006
Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.
Springer seminars in immunopathology·2006
Fcepsilon- and Fcgamma-receptor signaling in diseases.
Springer seminars in immunopathology·2006
Fc gamma receptors and cancer.
Springer seminars in immunopathology·2006
FcgammaRII and multi-system autoimmune disease.
Springer seminars in immunopathology·2006
Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity.
Springer seminars in immunopathology·2006
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026